Literature DB >> 28043879

[6]-gingerol and [6]-shogaol, active ingredients of the traditional Japanese medicine hangeshashinto, relief oral ulcerative mucositis-induced pain via action on Na+ channels.

Suzuro Hitomi1, Kentaro Ono2, Kiyoshi Terawaki3, Chinami Matsumoto3, Keita Mizuno3, Kiichiro Yamaguchi4, Ryota Imai3, Yuji Omiya3, Tomohisa Hattori3, Yoshio Kase3, Kiyotoshi Inenaga1.   

Abstract

The traditional Japanese herbal medicine hangeshashinto (HST) has beneficial effects for the treatment of oral ulcerative mucositis (OUM) in cancer patients. However, the ingredient-based mechanism that underlies its pain-relieving activity remains unknown. In the present study, to clarify the analgesic mechanism of HST on OUM-induced pain, we investigated putative HST ingredients showing antagonistic effects on Na+ channels in vitro and in vivo. A screen of 21 major ingredients using automated patch-clamp recordings in channel-expressing cells showed that [6]-gingerol and [6]-shogaol, two components of a Processed Ginger extract, considerably inhibited voltage-activated Na+ currents. These two ingredients inhibited the stimulant-induced release of substance P and action potential generation in cultured rat sensory neurons. A submucosal injection of a mixture of [6]-gingerol and [6]-shogaol increased the mechanical withdrawal threshold in healthy rats. In a rat OUM model, OUM-induced mechanical pain was alleviated 30min after the swab application of HST despite the absence of anti-bacterial and anti-inflammatory actions in the OUM area. A swab application of a mixture of [6]-gingerol and [6]-shogaol induced sufficient analgesia of OUM-induced mechanical or spontaneous pain when co-applied with a Ginseng extract containing abundant saponin. The Ginseng extract demonstrated an acceleration of substance permeability into the oral ulcer tissue without an analgesic effect. These findings suggest that Na+ channel blockage by gingerol/shogaol plays an essential role in HST-associated analgesia of OUM-induced pain. This pharmacological mechanism provides scientific evidence supporting the use of this herbal medicine in patients suffering from OUM-induced pain.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gingerol; Oral ulcerative mucositis; Shogaol; Traditional Japanese (Kampo) medicine; Voltage-dependent Na(+) channels; [6]-gingerol (PubChem CID: 442793); [6]-shogaol (PubChem CID: 5281794)

Mesh:

Substances:

Year:  2016        PMID: 28043879     DOI: 10.1016/j.phrs.2016.12.026

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  16 in total

1.  Isoliquiritigenin, an active ingredient of Glycyrrhiza, elicits antinociceptive effects via inhibition of Nav channels.

Authors:  Yuichi Miyamura; Suzuro Hitomi; Yuji Omiya; Izumi Ujihara; Shoichiro Kokabu; Yasuhiro Morimoto; Kentaro Ono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-06       Impact factor: 3.000

2.  Preparation and pharmaceutical properties of Hangeshashinto oral ointment and its safety and efficacy in Syrian hamsters with 5-fluorouracil-induced oral mucositis.

Authors:  Takashi Ogihara; Masato Kagawa; Rintarou Yamanaka; Satoshi Imai; Kotaro Itohara; Daiki Hira; Shunsaku Nakagawa; Atsushi Yonezawa; Michiho Ito; Takayuki Nakagawa; Tomohiro Terada; Kazuo Matsubara
Journal:  J Nat Med       Date:  2022-08-24       Impact factor: 3.192

3.  Novel curcumin analog (cis-trans curcumin) as ligand to adenosine receptors A2A and A2B: potential for therapeutics.

Authors:  Luke J Hamilton; Michaela Walker; Mahesh Pattabiraman; Haizhen A Zhong; Brandon Luedtke; Surabhi Chandra
Journal:  Pharmacol Res       Date:  2021-01-02       Impact factor: 7.658

4.  [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Leprdb/db type 2 diabetic mice.

Authors:  Mehdi Bin Samad; Md Nurul Absar Bin Mohsin; Bodiul Alam Razu; Mohammad Tashnim Hossain; Sinayat Mahzabeen; Naziat Unnoor; Ishrat Aklima Muna; Farjana Akhter; Ashraf Ul Kabir; J M A Hannan
Journal:  BMC Complement Altern Med       Date:  2017-08-09       Impact factor: 3.659

Review 5.  Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects.

Authors:  Qing-Yu Zhang; Fei-Xuan Wang; Ke-Ke Jia; Ling-Dong Kong
Journal:  Front Pharmacol       Date:  2018-11-06       Impact factor: 5.810

Review 6.  Natural Negative Allosteric Modulators of 5-HT₃ Receptors.

Authors:  Lina T Al Kury; Mohamed Mahgoub; Frank Christopher Howarth; Murat Oz
Journal:  Molecules       Date:  2018-12-03       Impact factor: 4.411

7.  Herb medicine for relieving radiation induced oral mucositis: A systematic review and meta-analysis protocol.

Authors:  Gui Wang; Liqun Jia
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

Review 8.  Understanding chemotherapy-induced intestinal mucositis and strategies to improve gut resilience.

Authors:  Alexander T Sougiannis; Brandon N VanderVeen; J Mark Davis; Daping Fan; E Angela Murphy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-01-20       Impact factor: 4.052

9.  Pharmacokinetics and Tissue Distribution of Gingerols and Shogaols from Ginger (Zingiber officinale Rosc.) in Rats by UPLC⁻Q-Exactive⁻HRMS.

Authors:  Ling-Ling Li; Ying Cui; Xing-Han Guo; Kai Ma; Ping Tian; Jing Feng; Jun-Ming Wang
Journal:  Molecules       Date:  2019-01-31       Impact factor: 4.411

10.  The Japanese herbal medicine Hangeshashinto enhances oral keratinocyte migration to facilitate healing of chemotherapy-induced oral ulcerative mucositis.

Authors:  Kanako Miyano; Moeko Eto; Suzuro Hitomi; Takashi Matsumoto; Seiya Hasegawa; Ayane Hirano; Kaori Nagabuchi; Noriho Asai; Miaki Uzu; Miki Nonaka; Yuji Omiya; Atsushi Kaneko; Kentaro Ono; Hideaki Fujii; Yoshikazu Higami; Toru Kono; Yasuhito Uezono
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.